share_log

Spyre Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Sloan Sheldon

SEC ·  Oct 1 18:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more